You may be a good candidate for Zepbound treatment if: Your BMI is 30 or higher, or Your BMI is 27 or higher with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol) If your BMI is under 27, you may still be a candidate to be prescribed Zepbound, depending on your medical history, lab results, or previous use of the medications
Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Ozempic) and chronic weight management (Wegovy), works through mechanisms that overlap with the physiological changes produced by sleeve gastrectomy
However, some patients may experience differences when switching between brands
Why Rochester-Area Residents Trust Vital Health Medical Care Rochester, New York, is a community with a strong tradition of medical excellence, anchored by institutions like the University of Rochester Medical Center and Rochester Regional Health
This dual action makes tirzepatide unique and more effective than many older diabetes or weight loss drugs
While early research shows promise, its important to approach this treatment with care, keeping in mind the potential risks and benefits